CVS Health Change in Accounts Payable 2010-2023 | CVS

CVS Health annual/quarterly change in accounts payable history and growth rate from 2010 to 2023. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
  • CVS Health change in accounts payable for the quarter ending December 31, 2023 was $3.618B, a 15.07% decline year-over-year.
  • CVS Health change in accounts payable for the twelve months ending December 31, 2023 was $4.763B, a 59% decline year-over-year.
  • CVS Health annual change in accounts payable for 2023 was $3.618B, a 15.07% decline from 2022.
  • CVS Health annual change in accounts payable for 2022 was $4.26B, a 47% increase from 2021.
  • CVS Health annual change in accounts payable for 2021 was $2.898B, a 4.66% increase from 2020.
CVS Health Annual Change in Accounts Payable
(Millions of US $)
2023 $3,618
2022 $4,260
2021 $2,898
2020 $2,769
2019 $3,550
2018 $2,329
2017 $1,710
2016 $2,189
2015 $2,834
2014 $1,742
2013 $1,024
2012 $1,147
2011 $1,128
2010 $-40
2009 $4
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $70.627B $357.776B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Walgreens (WBA) United States $15.434B 5.07
Herbalife (HLF) Cayman Islands $1.121B 5.19
China Jo-Jo Drugstores Holdings (CJJD) China $0.003B 0.00
GNC Holdings (GNC) United States $0.000B 0.00